Tag: HR 2026

HR 2026

Legislative

House Bill on Sharing Certain Information about Investigational Products Moves Forward

House Bill on Sharing Certain Information about Investigational Products Moves Forward

Jan. 22, 2018 – The House Energy and Commerce Subcommittee on Health held a markup Jan. 17 that advances H.R. 2026 (http://bit.ly/2G4cRM1), the “Pharmaceutical Information Exchange Act,” which will clarify how drug and medical device companies can share health care economic or scientific information about investigational drugs or devices with payers and formulary committees. “By […]

Read more